Some interesting statements in the quarterly filing.....
The 10-K filing the other day hinted about the possibility that something of significance might be happening near-term. Now, in the quarterly filing that came out today, there are these rather interesting statements......
The Company continues to pursue various activities to obtain additional capitalization, as described in the Company’s Annual Report on Form 10-K for the fiscal year ended 2008. A current focus is the launch of various products to support stem cell and drug development activities by our customers. Some of these products were completed to a market-ready stage during the first quarter of 2009. Subsequently, additional progress has been made and the Company is now beginning to introduce its products to commercial markets. The Company has also raised additional capital through sales of its securities, as described in Note H, Subsequent Events. However, additional expansion of the product line and aggressive marketing both require additional capital and management is activity seeking additional investment into the Company. Furthermore, management has been invited to present at a partnering forum organized by a major pharmaceutical company who is known to partner with and acquire biotechnology firms. Such discussions may lead to additional capitalization of the Company.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.